TherapeuticsMD | TXMD - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
AbbVie USD 10.27B 538M 2026-03
Alterity Therapeutics Limited AUD 8.67M 893.38K 2025-12
Cipla INR 60.98B 1.06B 2025-12
Clal Biotechnology ILS 5.15M 9.47M 2022-12
Compugen USD 11.29M 1.51M 2025-12
CSL USD 5.7B 2.82B 2025-12
Grifols EUR 1.99B 217.4M 2025-12
Novo Nordisk DKK 6.5B 32.8B 2025-06
Pfizer USD 90.1B 77.19B 2026-03
TherapeuticsMD USD 1.41M 50K 2024-06